Kangji Medical Holdings Limited (HKG:9997)

Market Cap	10.96B
Revenue (ttm)	1.15B
Net Income (ttm)	615.12M
Shares Out	1.21B
EPS (ttm)	0.52
PE Ratio	17.38
Forward PE	15.88
Dividend	0.26 (2.89%)
Ex-Dividend Date	May 27, 2025

Volume	3,324,000
Average Volume	2,393,723
Open	9.05
Previous Close	9.07
Day's Range	9.04 - 9.08
52-Week Range	5.50 - 9.07
Beta	0.28
RSI	71.87
Earnings Date	Nov 28, 2025

About Kangji Medical Holdings

Kangji Medical Holdings Limited, an investment holding company, designs, develops, manufactures, and sells minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, disposable trocars, disposable electrocoagulation forceps, ultrasonic scalpels, staplers and other disposable products. It provides reusable ultrasonic scalpels soft tissue cutting and hemostatic scalpel, and laparoscopic surgical instrument. In addition, the company offers instruments, including 4K UHD ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,007
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9997

Financial Performance

In 2024, Kangji Medical Holdings's revenue was 1.01 billion, an increase of 8.92% compared to the previous year's 926.02 million. Earnings were 581.44 million, an increase of 15.36%.

Financial numbers in CNY